NCT06692894View on ClinicalTrials.gov

Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
Myelodysplastic Syndromes, Adult
Interventions
OTHER

Observational

Blood will be collected from one cohort to identify potential blood biomarkers.

Trial Locations (1)

05495-2038

RECRUITING

University of Vermont, Burlington

All Listed Sponsors
lead

University of Vermont

OTHER